ABSTRACT
Acute pancreatitis (AP) is usually accompanied by intestinal failure, but its mechanism is still unclear. In AP patients, the functions of Paneth cells (lysozyme, HD5, Reg3γ, and Wnt3a) decreased. Compared with AP mice, injuries and inflammation of the pancreas and ileum were aggravated in AP mice treated with dithizone (Dith) (Dith+AP mice). Intestinal permeability and bacterial translocation were also increased. 16S rRNA sequencing showed that the gut microbiota of Dith mice and Dith+AP mice exhibited a marked increase in the pathogenic bacterium Helicobacter and a significant decrease in the probiotic bacterium Blautia. Lysozyme gavage in Dith+AP mice effectively alleviated injuries of the pancreas and small intestine. The beneficial effect of lysozyme was associated with a significant increase in the probiotic bacterium Blautia and a virtual absence of the pathogenic bacterium Helicobacter. The severity of AP in antibiotic-treated mice (ABX mice) was significantly aggravated when receiving feces from Dith mice and was markedly alleviated when receiving feces from lysozyme-gavaged mice. In vitro, lysozyme increased the proliferation of enteroids by promoting the activation of the Wnt pathway and Lgr5 expression in intestinal stem cells.
IMPORTANCE We demonstrate that AP patients and experimental AP mice exhibited a dysfunction of Paneth cells. Our in vivo research showed that the severity of AP was exacerbated by the long-term dysfunction of Paneth cells, which was associated with gut microbiota disorder. Restoring part of Paneth cell functions through lysozyme supplementation alleviated the severity of AP and gut microbiota dysbiosis. This study provides novel insight into the link of pancreas-gut interactions in the pathogenesis of AP, providing a new direction for the clinical treatment of intestinal complications during AP.
KEYWORDS: acute pancreatitis, Paneth cell, gut microbiota, lysozyme, intestinal enteroid
INTRODUCTION
Acute pancreatitis (AP) is one of the most common gastrointestinal diseases requiring urgent hospitalization (1). Approximately 20 to 30% of patients develop severe acute pancreatitis (SAP) with a substantial mortality rate of 20 to 40% (2). The translocation of intestinal bacteria and endotoxin after intestinal barrier injury is a key event leading to SAP (3). A growing number of studies revealed that intestinal microecology alteration is related to the development of AP, which includes microbiota dysbiosis, intestinal barrier damage, and immunological dysfunction (3–6). But the mechanisms have not yet been well understood and require further elucidation.
Paneth cells are highly differentiated secretory cells in the intestinal epithelium (7). They are distributed in the intestinal crypts and play an important role in the intestinal barrier. These cells secrete antimicrobial peptides (AMPs) such as lysozyme (Lyz) and α-defensin to maintain the homeostasis of the intestinal environment (8, 9). Paneth cells also serve as guardians of intestinal stem cells via providing essential cytokines such as Wnt3a and transforming growth factor β (TGFβ) (10). Their abnormality is related to the progression of a variety of diseases (11–13). Our previous study proved that the transient ablation of Paneth cells by dithizone (Dith) aggravated pancreatic and intestinal injuries in rat AP (14). An interaction exists between the gut microbiota and Paneth cells. Mice lacking the intestinal Sox9 protein presented an absence of Paneth cells accompanied by increases in Bacteroidetes and Enterococcus and a decrease in Bifidobacterium (15), while the gut microbiota regulates Paneth cell numbers and functions (16).
In this study, we explored the role of the gut microbiota regulated by Paneth cells in AP and the potential therapeutic effects of lysozyme on AP by in vivo and in vitro experiments.
RESULTS
Dysfunction of Paneth cells in AP patients and experimental AP mice.
We collected duodenal mucosa specimens by endoscopy from 21 AP patients and 14 healthy controls. AP patients were divided into two groups based on the course of the disease to explore whether the changes in Paneth cells were associated with the course of AP. No demographic differences were found among the three groups (see Table S1 in the supplemental material). Compared with healthy controls, Paneth cell counts and protein expression levels of lysozyme in the duodena were significantly decreased (P < 0.05) in AP patients in the early stage (<72 h) or with an onset time of <1 week (Fig. 1A and B). AP patients in the early stage had lower (P < 0.05) mRNA expression levels of lysozyme, human defensin 5 (HD5), HD6, regenerating islet-derived protein 3γ (Reg3γ), Wnt3a, and Lgr5 than did healthy controls (Fig. 1C to H). Significantly reduced mRNA expression levels (P < 0.05) of lysozyme, HD5, HD6, Reg3γ, and Wnt3a were also found in AP patients with an onset time of <1 week (Fig. 1C to H). However, compared with the healthy controls, the expression levels of angiogenin 4 (Ang4), secretory phospholipase A2 (sPLA2), and TGFβ did not change greatly, no matter how long the disease lasted (Fig. 1I to K). Therefore, dysfunctions of Paneth cells were detected in AP patients regardless of the course of the disease.
We applied three classical mouse models of AP, which were the L-arginine model (L-AP), the cerulein-plus-lipopolysaccharide (LPS) model (Cae-AP), and the Na-taurocholate model (N-AP), to further validate these findings. Compared with the control (Con) mice, the number of Paneth cells in crypts and the expression of lysozyme decreased significantly (P < 0.05) in the three AP models (Fig. 1L and M). Lysozyme, α-defensin 5 (Defa5), Reg3γ, Wnt3a, Lgr5, and TGFβ were reduced at the mRNA level (Fig. S1A and B).
Long-term reduction of Paneth cells aggravated AP-induced injuries, inflammation, and bacterial translocation.
In our previous study, rats were treated intraperitoneally with 100 mg/kg of body weight of dithizone (Dith) to ablate Paneth cells for 48 h (14). In this study, by increasing the frequency of injection and adjusting the dose of dithizone, the number of Paneth cells in mouse intestinal crypts and the expression of lysozyme and Defa5 decreased to approximately one-half of the original levels for 2 weeks (Fig. S2A to E). AP was induced by l-arginine on the basis of the long-term reduction of Paneth cells (Fig. S2A). Pancreatic pathological injuries and inflammation, amylase levels, and the pancreatic wet weight-to-dry weight (W/D) ratios of AP mice treated with Dith (Dith+AP mice) reached the highest levels 3 days following AP induction and were more severe (P < 0.05) than those of AP mice (Fig. 2A to D). Therefore, we chose 3 days as the optimal time for subsequent experiments.
Dith+AP mice also exhibited more severe ileal pathological injuries (P < 0.05) and more robust increases (P < 0.05) in serum and ileal proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin-6 [IL-6], and IL-1β) than did AP mice (Fig. 2E to K). Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) staining showed that the long-term reduction of Paneth cells caused more ileal apoptosis (P < 0.05) in Dith+AP mice (Fig. 2L). Compared with AP mice, the expression of tight junction proteins (TJPs) (claudin1, occludin, and ZO-1) decreased in Dith+AP mice (Fig. 3A to D). Serum diamine oxidase (DAO) and d-lactate levels were also higher in Dith+AP mice than in AP mice (P < 0.05), suggesting increased intestinal permeability (Fig. 3E).
It has been proven that Paneth cells constituted the niche for Lgr5-positive (Lgr5+) stem cells in intestinal crypts by secreting Wnt3a and TGFβ, etc. (10). Compared with AP mice, the expression levels of Wnt3a, TGFβ, and Lgr5 were significantly downregulated (P < 0.05) in Dith+AP mice (Fig. 3F to I). Proliferating cell nuclear antigen (PCNA) staining showed that the reduction of Paneth cells inhibited the proliferation of intestinal epithelial cells (IECs) in Dith+AP mice (Fig. 3J).
The progression of AP involves an increase in bacterial translocation caused by the disrupted intestinal barriers. Dith+AP mice harbored a higher level of endotoxin (P < 0.05) than did AP mice (Fig. 4A). Compared with AP mice, no bacterial translocation was found in Dith mice, while Dith+AP mice presented increased bacterial translocation to the intestinal mucosa and pancreas using fluorescence in situ hybridization (FISH) analysis (Fig. 4B to E). The numbers of anaerobic bacteria in the liver and mesenteric lymph nodes (MLN) were counted on a brain heart infusion agar (BHIA) plate. Compared with AP mice, Dith+AP mice had more CFU (P < 0.05), indicating that the liver and mesenteric lymph nodes of Dith+AP mice had more severe bacterial translocation (Fig. 4F and G).
The aggravation of AP in Dith mice was related to the disturbance of the intestinal microbiota.
To explore the role of the gut microbiota in exacerbated injuries and inflammation in Dith+AP mice, we transplanted the fecal microbiota of Dith mice and Con mice to antibiotic-treated mice (ABX mice), followed by the induction of AP. Compared with those in ABX mice receiving feces from Con mice, pathological damage and the mRNA expression levels of TNF-α, IL-6, and IL-1β were increased significantly (P < 0.05) in both the pancreatic and ileal tissues of ABX mice receiving feces from Dith mice (Fig. 5A to D).
We then analyzed the cecal contents by 16S rRNA sequencing. Principal-coordinate analysis (PCoA) showed that the intestinal microbiota of AP mice was largely separated from that of Con mice. Simultaneously, different bacterial communities were revealed between Con mice and Dith mice. There was a partial overlap between bacterial communities in Dith and Dith+AP mice (Fig. 5E). Compared with Con mice, the alpha diversity of bacterial communities was greatly decreased in Dith mice, as reflected by the decreased Shannon index (P < 0.05) and the increased Simpson index (P < 0.05) (Fig. 5F to H). Compared with AP mice, the alpha diversity was also markedly decreased in Dith+AP mice, as evidenced by the decreased Shannon index and Chao1 index and the increased Simpson index (Fig. 5F to H).
Firmicutes and Bacteroidetes are two dominant bacteria at the phylum level (17). An increase in the relative abundance of Firmicutes and a decrease in the relative abundance of Bacteroidetes resulted in an increase in the Firmicutes/Bacteroidetes (F/B) ratio (P < 0.05) in Dith mice and Dith+AP mice (Fig. 5I and J; Fig. S3A). The relative abundance of Proteobacteria, which include Escherichia-Shigella, Helicobacter, and other pathogenic bacteria (18), also tended to increase in Dith mice and Dith+AP mice (P < 0.05) (Fig. 5I and J).
Next, we performed linear discriminant analysis (LDA) coupled with effect size (LEfSe) on the gut microbiota between Con mice and Dith mice with or without AP. At the genus level, the relative abundances of Bacteroides and Helicobacter increased significantly (P < 0.05) while the relative abundance of Blautia decreased markedly (P < 0.05) in Dith mice and Dith+AP mice (Fig. 6A and B). Spearman’s correlation analysis showed that the relative abundance of Helicobacter is positively correlated with the pancreatic and ileal histopathological scores and the levels of serum DAO and d-lactate, serum proinflammatory cytokines, and pancreatic myeloperoxidase (MPO). In contrast, the relative abundance of Blautia was negatively associated with the ileal histopathological score, serum IL-6, pancreatic MPO, and endotoxin (Fig. 6C).
Lysozyme ameliorated AP-induced injuries and inflammation in Dith mice.
The functional recovery of Paneth cells has been reported to effectively correct intestinal dysbiosis (19). We next evaluated the therapeutic potential of AMPs of Paneth cells in AP mice. Compared with AP mice, the mRNA expression levels of lysozyme (Lyz), Defa5, Reg3γ, Reg3β, Ang4, and cryptdin1 in Dith+AP mice decreased significantly (P < 0.05), while the mRNA expression levels of matrix metalloproteinase 7 (MMP7) and sPLA2 were not significantly altered (Fig. S4A). The protein expression levels of lysozyme, Defa5, and Ang4 were downregulated in Dith+AP mice (Fig. S4B and Fig. S6A). Spearman’s correlation analysis revealed that the severity of AP was inversely associated with the levels of Paneth cell AMPs, where lysozyme harbored the highest correlation coefficient (Fig. S4C). Therefore, we chose supplementation with lysozyme for the functional recovery of Paneth cells to restore intestinal homeostasis.
We observed less severe pancreatic injuries and apoptosis as well as much lower amylase levels and pancreatic W/D ratios in Lyz+Dith+AP mice than in Dith+AP mice (P < 0.05) (Fig. 7A to D). Pancreatic inflammation was attenuated in Lyz+Dith+AP mice (P < 0.05), as evidenced by the decline in proinflammatory cytokines (Fig. 7E). Compared with Dith+AP mice, Lyz+Dith+AP mice also showed mild intestinal epithelial injuries and apoptosis along with decreased ileal and systematic inflammation (P < 0.05) (Fig. 7F to H).
Lysozyme restored intestinal barrier integrity and protected against bacterial translocation.
The expression of the TJPs (claudin1, occludin, and ZO-1) was increased following lysozyme administration in Dith+AP mice (Fig. S4D to G). The mRNA expression of Wnt3a, TGFβ, and Lgr5 and the protein expression of Lgr5 were restored in Lyz+Dith+AP mice (Fig. 8A and B). Moreover, lysozyme supplementation restored the proliferation of IECs, which was suppressed in Dith+AP mice, as determined by PCNA staining (Fig. 8C).
Lyz+Dith+AP mice presented lower intestinal permeability than Dith+AP mice, based on measurements of serum levels of d-lactate, DAO, and endotoxin (P < 0.05) (Fig. 8D to F). The FISH analysis confirmed decreased numbers of bacteria within the intestinal mucosa and the pancreas of Lyz+Dith+AP mice versus Dith+AP mice (Fig. 8G and H). The numbers of anaerobes translocated to the liver and mesenteric lymph nodes were also reduced significantly in Lyz+Dith+AP mice (P < 0.05) (Fig. 8I and J). These results suggested that pretreatment with lysozyme attenuated AP by reducing bacterial translocation and promoted mucosal repair by stimulating the proliferation of IECs.
Lysozyme regulated microbiota disorders induced by dysfunction of Paneth cells.
We then evaluated the contribution of the lysozyme-modulated microbiota in Dith+AP mice by fecal microbiota transplantation (FMT). The fecal microbiota of Lyz+Dith mice and Dith mice was transplanted to ABX mice, followed by the induction of AP. ABX mice receiving feces from Lyz+Dith mice developed less severe pancreatic and ileal injuries (P < 0.05) than those receiving feces from Dith mice (Fig. 9A to C). Alleviation of pancreatic and ileal inflammation was evidenced by reduced proinflammatory cytokines (P < 0.05) by real-time PCR in ABX mice receiving FMT from Lyz+Dith mice compared with those receiving FMT from Dith mice (Fig. 9D and E). Therefore, lysozyme markedly reduced the severity of AP exacerbated in Dith+AP mice via regulating the gut microbiota.
PCoA showed that lysozyme gavage greatly shifted the microbiota structure in Dith+AP mice (Fig. 9F). Compared with Dith+AP mice, the increased Chao1 index and Shannon index (P < 0.05) and decreased Simpson index (P < 0.05) showed increased the alpha diversity of bacterial communities in Lyz+Dith+AP mice (Fig. 9G to I). At the phylum level, compared with Dith+AP mice, Lyz+Dith+AP mice presented an increased relative abundance of Firmicutes (P < 0.05), decreased relative abundances of Bacteroidetes and Proteobacteria (P < 0.05), and a normalized F/B ratio (P < 0.05) (Fig. 9J; Fig. S3B). At the genus level, supplementation with lysozyme restored the relative abundances of Helicobacter and Blautia in Dith+AP mice (P < 0.05) (Fig. 9K). Therefore, lysozyme could restructure the microbiota composition disrupted in Dith+AP mice.
We then carried out real-time PCR for four prevalent species of Helicobacter and three prevalent species of Blautia (20, 21) (Fig. S3C). Compared with the Con group, the levels of Helicobacter felis, Helicobacter hepaticus, and Blautia coccoides increased significantly and the level of Blautia obeum decreased greatly in the Dith group, and the levels of Helicobacter bilis, H. hepaticus, and Blautia wexlerae increased significantly and the level of B. obeum decreased greatly in the AP group. Compared with AP group, the levels of H. bilis, H. felis, B. coccoides, B. obeum, and B. wexlerae decreased greatly and the level of H. hepaticus increased significantly in the Dith+AP group. Compared with the Dith+AP group, the levels of H. felis, B. obeum, and B. wexlerae increased greatly and the levels of H. hepaticus and B. coccoides decreased significantly in the Lyz+Dith+AP group. Although an association of Helicobacter pylori with prolonged hospital stay in AP patients has been reported previously (22), H. pylori cannot be detected by real-time PCR in the contents of the cecum (data not shown) in our research. The possible significance of specific species is discussed in Discussion.
Lysozyme promoted enteroid proliferation by regulating the functions of Paneth cells.
We cultured enteroids to investigate IEC-lysozyme interactions based on the well-established technology of three-dimensional (3D) culture. Compared with the Con group, we observed that after 72 h of intervention with lysozyme, both the surface area and the number of crypt buds per enteroid increased significantly (P < 0.05) (Fig. 10A to C) (23). Lysozyme administration also promoted the proliferation of enteroids, as reflected by increases in the expression of PCNA, TJPs (occludin and claudin1), and Lgr5 (P < 0.05) (Fig. 10D to F; Fig. S6B). Compared with the Con group, Wnt3a and TGFβ, along with β-catenin and c-myc, two crucial molecules of the Wnt signaling pathway (24, 25), were significantly upregulated (P < 0.05) in the Lyz group (Fig. 10F to H; Fig. S6B). In addition, the mRNA expression of AMPs (lysozyme, Defa5, Reg3γ, and Ang4) was also increased greatly (P < 0.05) in the Lyz group (Fig. 10I; Fig. S5A to D).
LPS was utilized to imitate the inflammatory microenvironment in the enteroid system (26). In the Lyz+LPS group, the release of proinflammatory factors was decreased (P < 0.05) (Fig. 10J), while cell proliferation and the integrity of the intercellular TJPs, which were disrupted in the LPS group, were protected by lysozyme (Fig. 10D to H; Fig. S6B). Note that lysozyme failed to reverse the reduction of AMPs in Paneth cells induced by LPS (Fig. 10I; Fig. S5A to D).
DISCUSSION
In this study, we first confirmed the dysfunction of Paneth cells in AP patients. Our in vivo experiments showed that the long-term reduction of Paneth cells exacerbated injuries and inflammation in the pancreas and small intestine in AP mice. Dith+AP mice also presented with increased intestinal permeability, bacterial translocation, and intestinal microbiota disorder compared with AP mice. Such changes were significantly reversed by lysozyme treatment. The functional recovery of Paneth cells might be a novel target for the treatment of intestinal dysfunction during AP.
Paneth cells constitute a part of innate immunity by secreting various antimicrobial peptides. A high concentration of antimicrobial peptides in crypts constructs a relatively sterile environment and prevents pathogen invasion (27). The involvement of Paneth cell dysfunction in the pathogenesis of multiple diseases has been widely reported, such as in Crohn’s disease (CD) (11), alcoholic steatohepatitis (28), graft-versus-host disease (GVHD) (29), and irritable bowel syndrome (IBS) (15), etc. The dysfunction of Paneth cells in AP patients and AP mice, manifested by the marked reduction in the number of Paneth cells and the expression of AMPs, was in line with previous findings in rats (30). Our previous study demonstrated that acute ablation of Paneth cells using dithizone aggravated the severity of rat AP, but the mechanism of the protective role of Paneth cells in AP remains unclear (14). Therefore, we established a model with a long-term reduction of Paneth cells. Inflammation and damage were significantly increased in the pancreas and small intestine of Dith+AP mice compared with those of AP mice.
AP is often accompanied by intestinal barrier dysfunction, and the translocation of bacteria derived from the small intestine exacerbates systemic inflammation (31). Intestinal dysfunction in AP is thought to be associated with ischemia-reperfusion damage, severe oxidative stress, and apoptosis in the intestinal mucosa (32, 33). In recent years, Paneth cells have been proven to regulate the proliferation of intestinal stem cells and maintain the dynamic balance of intestinal epithelial cells by secreting support factors (10). Bifidobacterium longum promotes cell proliferation and the expression of Lgr5 and Wnt3a in intestinal organoids by regulating the functions of Paneth cells (34). VDRΔPC mice exhibited abnormal Paneth cells and decreased expression of PCNA and β-catenin (35). Our study found that compared with AP mice, Dith+AP mice exhibited markedly decreased TJP expression and increased intestinal permeability and bacterial translocation. Meanwhile, the expression of Lgr5, Wnt3a, and TGFβ and intestinal epithelial proliferation were also significantly reduced. These findings suggested that Paneth cell dysfunction resulting in its diminished support for intestinal stem cells was one of the reasons for increased intestinal permeability during AP.
Intestinal microbiota disorders are common in patients with moderate or severe AP and are significantly related to the severity of inflammation, indicating that the intestinal microbiota is involved in the progression of AP (5). The administration of Escherichia coli MG1655 to AP rats aggravated injuries in the pancreas and small intestine and activated Toll-like receptor 4 (TLR4)/MyD88/mitogen-activated protein kinase (MAPK) and endoplasmic reticulum stress in intestinal epithelial cells, while Parabacteroides produces acetate to alleviate heparanase-exacerbated AP by reducing neutrophil infiltration (36, 37). The significantly reduced inflammation in ABX mice with AP further proved the role of the gut microbiota in AP (36, 38). Paneth cells protect the host from intestinal pathogens and shape the composition of the colonized microbiota. FMT proved that gut microbiota disturbance caused by the long-term reduction of Paneth cells played an important role in AP aggravation. 16S rRNA sequencing of cecal contents revealed that the long-term reduction of Paneth cells altered the gut microbiota structure, decreased richness and diversity, increased the relative abundance of the deleterious bacterium Helicobacter, and decreased the relative abundance of the beneficial bacterium Blautia.
Supplementing products of Paneth cells as functional recovery is a commonly used method in studies related to Paneth cell dysfunction. HD5 supplementation effectively altered the gut microbiota in alcoholic hepatitis and reversed alcohol-induced damage (28). Lysozyme supplementation prevented Escherichia coli expansion and visceral hypersensitivity during maternal isolation (15). ANG1 treatment prevented dysbiosis in mice and alleviated dextran sulfate sodium (DSS)-induced colitis (39). The overexpression of Reg3γ protected mice from alcoholic hepatitis and reduced bacterial translocation (40). Supplementation of lysozyme was most appropriate for the functional recovery of Paneth cells in our study. Pretreatment with lysozyme restored gut microbiota disturbance, reduced the relative abundance of Helicobacter, restored the relative abundance of Blautia, and reversed aggravated ileal and pancreatic injuries in Dith+AP mice. FMT further confirmed that Paneth cells played a protective role in AP by stabilizing the intestinal microbiota.
Lysozyme is a cornerstone of innate immunity. Previous in vitro studies showed that lysozyme is a nonspecific antimicrobial peptide, while different bacteria possessed distinct sensitivities to lysozyme (41–44). Although in our research, H. pylori cannot be detected by real-time PCR, studies have shown that H. pylori-positive patients exhibited a higher relative abundance of Proteobacteria (45). The changes in H. hepaticus and B. obeum are of concern and warrant further research (see Fig. S3C in the supplemental material). Previous studies demonstrated that cytolethal distending toxin subunit B (CdtB) produced by H. hepaticus exacerbated the severity of colitis via inducing an inflammatory response and activating the Jak-Stat signaling pathway (46, 47). B. obeum generating bile salt hydrolases (BSHs) could inhibit the growth and colonization of Vibrio cholerae and Clostridioides difficile (48, 49). These studies suggested that changes of H. hepaticus and B. obeum might be involved in the progression of AP. The role of species altered by Paneth cell depletion or lysozyme supplementation in AP requires further investigation.
In addition to the antimicrobial effect, lysozyme modulated innate immunity. The sensing of the lysozyme-mediated production of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) stimulated downstream proinflammatory signaling and the production of proinflammatory cytokines (50, 51). Lysozyme could also limit intestinal inflammation. Zhang et al. showed that intestinal inflammation was associated with a failure to secrete Paneth cell lysozyme in a mouse model of Crohn’s disease (52, 53). Furthermore, lysozyme supplementation could ameliorate intestinal inflammation in porcine colitis (54). The mechanisms of lysozyme limiting intestinal inflammation were still unclear, with speculation of limited bacterial invasion and activated protective intestinal immune responses.
Organoid techniques have become a powerful tool for studying the intestinal epithelium in vitro (55, 56). Lysozyme intervention promoted the growth of organoids, activated the Wnt pathway, and promoted epithelial proliferation. Therefore, lysozyme secreted by Paneth cells not only maintains microbiota homeostasis but also promotes the proliferation of the intestinal organoids. Further studies designed to explore possible mechanisms should be performed.
We first used the method of multiple intraperitoneal injections of dithizone to maintain Paneth cells at a low level, but this method still had limitations. The protective effect of the functional recovery of Paneth cells in AP mice provides new strategies for the clinical treatment of intestinal complications during AP.
MATERIALS AND METHODS
Human intestinal biopsy specimens.
After obtaining written informed consent, human intestinal biopsy specimens from the descending part of the duodenum of 21 patients with AP and 14 healthy controls were obtained upon endoscopy from the Department of Gastroenterology of Shanghai General Hospital, excluding individuals with diseases affecting Paneth cells, including irritable bowel syndrome, inflammatory bowel disease, and alcoholic liver disease, etc. There was no statistical difference in baseline demographic and clinical characteristics between AP patients and healthy controls (see Table S1 in the supplemental material). Biopsy specimens were stored in 4% paraformaldehyde or liquid nitrogen.
Animals.
Male C57BL/6 mice (6 to 8 weeks of age, 20 to 25 g) were obtained from Shanghai SLAC Laboratory Animal Co. Mice were housed under specific-pathogen-free (SPF) conditions with a room temperature of 24°C ± 2°C and a 12-h light/dark cycle.
Experimental design.
Mice were randomly divided into 5 groups (n = 6): a control (Con) group, a dithizone (Dith) group, an AP group, a Dith+AP group, and a lysozyme (Lyz)-treated (Lyz+Dith+AP) group. Mice in the Dith group, the Dith+AP group, and the Lyz+Dith+AP group were intraperitoneally injected with 40 mg/kg dithizone (Sigma-Aldrich, USA) every 3 days for 2 weeks. The mice in the Lyz+Dith+AP group received an oral gavage of 200 U/day lysozyme (Sigma-Aldrich, USA) for 2 weeks. Mice in the Con group and the AP group were intraperitoneally injected with normal saline (NS). After treatment with dithizone or NS, mice in the AP group, the Dith+AP group, and the Lyz+Dith+AP group were injected intraperitoneally twice with 4.5 g/kg l-arginine (Sigma-Aldrich, USA). Mice in the Con group and the Dith group were intraperitoneally injected with NS. Mice in the Cae+AP group were injected intraperitoneally with 100 μg/kg cerulein (MedChemExpress, China) 10 times, with an hour interval between consecutive injections. After the final injection, 5 mg/kg lipopolysaccharide (Sigma-Aldrich, USA) was intraperitoneally injected. AP was induced in mice in the N+AP group as previously described (57). A 2% sodium taurocholate (Sigma-Aldrich, USA) solution at a volume of 50 μL/20 g of body weight was infused into the biliopancreatic duct at a rate of 5 μL/min. Mice were anesthetized with tiletamine and zolazepam (Virbac, France) and then sacrificed 72 h after the first injection of l-arginine. Blood samples, distal ileum, pancreas, liver, and mesenteric lymph nodes were collected and stored at −80°C or in 4% paraformaldehyde. Fresh contents of the ileocecum were also collected for analysis of the gut microbiota.
Histological analysis.
Fresh pancreas and distal ileum were soaked in 4% paraformaldehyde and dehydrated. Tissues were then embedded in paraffin and cut into sections of 4 μm. Sections were stained with hematoxylin and eosin (H&E; Servicebio, China) as previously described (58). Histopathological injuries were examined by using a light microscope (Leica, Germany). Pancreatic injury was assessed according to the scoring criteria reported previously by Shimizu et al. (59), while distal ileal injury was evaluated as described previously by Chiu et al. (60). Paneth cells were counted as previously reported (61).
Real-time PCR.
Tissue total RNA was extracted using TRIzol (Invitrogen, USA) and tissue RNA purification kit plus (EZBioscience, USA). cDNA synthesis was performed using HyperScript III RT SuperMix (EnzyArtisan, China) for quantitative PCR (qPCR) with genomic DNA (gDNA) remover. Bacterial DNA was extracted from fecal samples with an E.Z.N.A. stool DNA kit (Omega, USA). The concentration of RNA or DNA was determined by using a NanoDrop2000 instrument (Thermo Scientific, USA). S6 universal SYBR qPCR mix (2×) (EnzyArtisan, China) was used to perform real-time PCR with QuantStudio 6 Flex real-time PCR systems (Thermo Scientific, USA) according to the following protocol: predenaturation (95°C for 30 s), 40 amplification cycles of denaturation (95°C for 10 s), and annealing and extension (60°C for 30 s). Gene expression was measured by the 2−ΔΔCT method. Primers used for detection are provided in Table S2.
Pancreas W/D ratio and serum amylase assays.
The pancreatic tissue was weighed and then incubated at 80°C for 48 h to obtain a constant weight as the dry weight. The ratio of the wet pancreas weight to the dry pancreas weight (W/D ratio) was calculated to evaluate tissue edema. The level of serum amylase was determined with amylase reagents using the Advia 2400 chemistry system (Siemens, German) according to the technicians’ instructions.
Immunofluorescence.
Distal ileal sections were heated at 60°C for 1 h. Next, sections were put in Leica Autostainer XL (Leica, USA) (xylene for 40 min, 100% ethanol for 10 min, 95% ethanol for 10 min, 80% ethanol for 5 min, 70% ethanol for 5 min, and doubly distilled water for 3 min) to deparaffinize and rehydrate the samples. Antigens were retrieved using a citrate antigen retrieval solution (Sangon Biotech, China). After repeated washing in phosphate-buffered saline (PBS), a super pap pen (Sangon Biotech, China) was used to draw a circle around the tissue. Slides were blocked with immunostaining blocking buffer (Sangon Biotech, China) at room temperature for 1 h and incubated with primary antibodies against PCNA (catalog number A0264; Abclonal, China), occludin (catalog number A2601; Abclonal, China), claudin1 (catalog number ab211737; Abcam, USA), and ZO-1 (catalog number 13663; Cell Signaling Technology, USA) diluted with primary antibody dilution buffer (Sangon Biotech, China) at 4°C overnight. Slides were washed with PBS and incubated with Alexa Fluor 488 AffiniPure donkey anti-rabbit IgG (Yeason, China) for 1 h at room temperature. Next, the slides were washed with PBS and stained with dihydrochloride (Yeason, China) for 10 min. Images were captured with a fluorescence microscope (Leica, USA).
Western blotting.
Distal ileum tissues were lysed in radioimmunoprecipitation assay (RIPA) lysis buffer (Epizyme Biotech, China) with 1% protease inhibitor (Epizyme Biotech, China) and fully ground using a high-throughput tissue grinder (Onebio Biotech, China). The suspension was left to settle on ice for 1 h and centrifuged at 10,000 × g for 10 min at 4°C. After taking the supernatant and mixing it with SDS loading buffer (Yeason, China), the mixed solution was heated at 100°C for 10 min. Ten microliters of the solution was loaded into a 10% SDS-PAGE gel produced by using a PAGE gel fast preparation kit (Epizyme Biotech, China) for electrophoresis. Next, proteins in the gel were transferred to a 0.2-μm polyvinylidene difluoride (PVDF) membrane (Millipore, USA). The membrane was blocked with 3% bovine serum albumin (BSA) for 1 h and incubated with primary antibodies, diluted in primary antibody dilution buffer (Epizyme Biotech, China), against Lgr5 (catalog number A10545; Abclonal, China), lysozyme (catalog number A0099; Dako, Denmark), Reg3γ (catalog number sc-377038; Santa Cruz Biotechnology, USA), Defa5 (catalog number A18208; Abclonal, China), Ang4 (catalog number sc-377497; Santa Cruz Biotechnology, USA), and sPLA2 (catalog number sc-58363; Santa Cruz Biotechnology, USA) overnight at 4°C. On the second day, the membrane was washed 3 times with Tris-buffered saline with Tween 20 (TBST) buffer and incubated with peroxidase-conjugated goat anti-rabbit IgG(H+L) (Yeason, China) for 60 min at room temperature. The membrane was washed 3 times with TBST again. Bands were visualized with a horseradish peroxidase (HRP) substrate peroxide solution (Millipore, USA) using an Amersham 600 imager (General Electric, USA).
Enzyme-linked immunosorbent assay.
The levels of IL-1β, TNF-α, and IL-6 in the serum, pancreas, and ileum were determined by using a Luminex mouse discovery assay kit (R&D Systems, USA) according to the manufacturer’s instructions. The levels of pancreatic MPO, serum endotoxin, DAO, and d-lactate were measured using an MPO mouse enzyme-linked immunosorbent assay (ELISA) kit, an endotoxin mouse ELISA kit, a DAO mouse ELISA kit, and a d-lactate mouse ELISA kit (MultiSciences Biotech, China) according to the provided protocols.
TUNEL and FISH assays.
Apoptosis was evaluated by a TUNEL assay using a fluorescein TUNEL cell apoptosis detection kit (Servicebio, China) according to the manufacturer’s instructions. Pancreatic and ileal TUNEL-positive cell counting was performed at a ×200 magnification. Fluorescence in situ hybridization (FISH) was used to detect bacterial translocation. In short, sections of the distal ileum and pancreas were heated for 60 min and dewaxed (twice for 10 min with 100% xylene and 5 min with 100% ethanol). Next, sections were incubated with specific probes (EUB338 [5′-Cy3-GCTGCCTCCCGTAGGAGT-3′]) in a wet box at 52°C for 18 h. The sections were then washed and stained with 4′,6-diamidino-2-phenylindole (DAPI). Images were captured with a fluorescence microscope (Leica, USA).
Bacterial cultures and plate counting.
Mesenteric lymph nodes and liver tissues were collected in sterile PBS, fully ground using a high-throughput tissue grinder (Onebio Biotech, China), and plated onto brain heart infusion agar plates for a culture of anaerobic bacteria. The plates were incubated for 48 h at 37°C using Oxoid AnaeroGen 2.5 L and an Oxoid resazurin anaerobic indicator (Thermo Scientific, USA). The plates producing 25 to 250 CFU were counted.
Fecal microbiota transplantation.
Feces were collected from Con mice, Dith mice, and Dith+Lyz mice. Processing of the fecal microbiota transplantation (FMT) suspension was done within 2 h. One hundred milligrams of feces was resuspended in 1 mL of saline and centrifuged for 5 min. The supernatant was used as the FMT suspension. The mice receiving antibiotics were treated with vancomycin (0.5 mg/mL), neomycin (1 mg/mL), ampicillin (1 mg/mL), and metronidazole (1 mg/mL) (Sangon Biotech, China) in their drinking water for 4 weeks. Mice were divided into four groups: the Con group, the ABX+Con group, the ABX+Dith group, and the ABX+Dith+Lyz group. The Con group received no treatment. The ABX+Con group was gavaged with feces from a control mouse for 1 week, the ABX+Dith group was gavaged with 200 μL of an FMT suspension from Dith mice for 1 week, and the ABX+Dith+Lyz group was gavaged with 200 μL of an FMT suspension from Dith+Lyz mice for 1 week. AP was induced in mice from the ABX+Con group, the ABX+Dith group, and the ABX+Dith+Lyz group.
16S rRNA sequencing.
Genomic DNA was extracted from the contents of the ileocecum using the E.Z.N.A. stool DNA kit (Omega, USA) according to the manufacturer’s instructions and amplified using forward primer 5′-TACGGRAGGCAGCAG-3′ and reverse primer 5′-AGGGTATCTAATCCT-3′. 16S rRNA high-throughput sequencing was performed on an Illumina HiSeq platform (Illumina, USA) according to standard protocols by Majorbio Bio-Pharm Technology.
Microbiome analysis.
The sequences were filtered with fastp (0.19.6) and merged with FLASH (v1.2.11). Next, the high-quality sequences were denoised using the DADA2 plug-in in the QIIME2 (version 2020.2) pipeline with recommended parameters, which are called amplicon sequence variants (ASVs). Taxonomic assignment of ASVs was performed using the naive Bayes consensus taxonomy classifier implemented in QIIME2 and the SILVA 16S rRNA database (v138). Analysis of the gut microbiota was carried out using the Majorbio Cloud platform (https://cloud.majorbio.com). Alpha diversity indices, including Chao1 richness, the Shannon index, and the Simpson index, were calculated with Mothur v1.30.1. Principal-coordinate analysis (PCoA) based on Bray-Curtis dissimilarity using the Vegan v2.5-3 package was performed to analyze the microbial communities in different samples. The linear discriminant analysis (LDA) effect size (LEfSe) algorithm was performed to identify the significantly abundant genera of bacteria among the different groups (LDA score of >2; P < 0.05). Correlations among histopathological score, serum d-lactate and DAO, serum inflammation factors, endotoxin, and the relative abundances of different genera were calculated using Spearman’s analysis.
Enteroid establishment and coculture with lysozyme.
Enteroids were obtained from C57BL/6 mice. The distal 10 cm of the small intestine was collected and flushed gently with ice-cold PBS for 5 min. Next, the intestine was cut open along the longitudinal axis and cut into 2-mm segments. Crypts were isolated from the segments by incubation in 2 mM EDTA for 30 min and then in 5 mM EDTA for 30 min. After 5 min of resting, the supernatant was removed. Crypts were resuspended in 15 mL Dulbecco’s modified Eagle’s medium (DMEM)–F-12 medium (Wisent, China) with repeated blowing. Next, the suspension was filtered through a 70-μm filter mesh (BD Biosciences, USA) and centrifuged at 300 × g for 5 min. After the supernatant was discarded, the pellet was mixed with Matrigel (Corning, USA) and DMEM–F-12 medium in a 1:1 ratio. Next, 50 μL of the suspension was plated into each well of prewarmed 24-well plates, and 700 μL of IntestiCult organoid growth medium (mouse) (Stemcell Technologies, Canada) was added per well. In the following culture, half of the medium was replaced every 3 days and passaged every 9 days. Lysozyme (200 U) was added to enteroids in each well, and the mixture was incubated at 37°C with 5% CO2 for 72 h. A total of 1 mg/mL LPS and 200 U lysozyme were added to enteroids in each well, and the mixture was incubated for 24 h. Total RNA was extracted using an EZ-press RNA purification kit (EZBioscience, USA). The methods for real-time PCR, Western blotting, and immunofluorescence analysis of enteroids are the same as the ones described above.
Statistical analysis.
Data are exhibited in the form of means ± standard deviations (SD). Comparisons between two groups with a normal distribution were performed by a t test. Spearman’s rank correlation coefficient was used to determine correlations between bacterial genus and indicators. One-way analysis of variance (ANOVA) was performed for three or more groups. Differences in the male/female ratio and body mass index (BMI) between groups were tested by the chi-square test. All the statistical analyses were carried out in IBM SPSS Statistics 25. A P value of ≤0.05 suggested a statistically significant difference.
Study approval.
All studies involving human samples were approved by the Ethics Committee of Shanghai General Hospital (2021035) and registered in the Chinese Clinical Trial Registry (identifier ChiCTR1800017214). All the animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai General Hospital (2020AW095) and conducted according to the instructions of the IACUC.
Data availability.
The raw data for 16S rRNA sequencing in this study are available in the SRA database with BioProject accession number PRJNA774193.
Supplementary Material
ACKNOWLEDGMENTS
We declare that no conflict of interest exists.
This work was financially supported by the Clinical Research Plan of SHDC (SHDC2020CR2014A) and the National Natural Science Foundation of China (81970555).
Y.F. and Y.Z. designed the studies. Y.F., Q.M., and N.Y. performed experiments and acquired data. B.L. and S.L. obtained human intestinal biopsy specimens. Z.H. and B.X. analyzed and interpreted the data. Y.F. drafted the manuscript. J.F., C.H., and Y.Z. revised the manuscript critically with important intellectual contents. All authors approved the final version of the manuscript.
Contributor Information
Junjie Fan, Email: 956937215@qq.com.
Chunlan Huang, Email: huangchl@hotmail.com.
Yue Zeng, Email: carrie_1004@sjtu.edu.cn.
Janet K. Jansson, Pacific Northwest National Laboratory
Kazuyuki Kasahara, Nanyang Technological University.
Pradeep Bist, Duke-Nus Medical School.
REFERENCES
- 1.Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. 2019. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 156:254–272.e11. doi: 10.1053/j.gastro.2018.08.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. 2020. Acute pancreatitis. Lancet 396:726–734. doi: 10.1016/S0140-6736(20)31310-6. [DOI] [PubMed] [Google Scholar]
- 3.Fritz S, Hackert T, Hartwig W, Rossmanith F, Strobel O, Schneider L, Will-Schweiger K, Kommerell M, Büchler MW, Werner J. 2010. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg 200:111–117. doi: 10.1016/j.amjsurg.2009.08.019. [DOI] [PubMed] [Google Scholar]
- 4.Van Felius ID, Akkermans LM, Bosscha K, Verheem A, Harmsen W, Visser MR, Gooszen HG. 2003. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 15:267–276. doi: 10.1046/j.1365-2982.2003.00410.x. [DOI] [PubMed] [Google Scholar]
- 5.Tan C, Ling Z, Huang Y, Cao Y, Liu Q, Cai T, Yuan H, Liu C, Li Y, Xu K. 2015. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis. Pancreas 44:868–875. doi: 10.1097/MPA.0000000000000355. [DOI] [PubMed] [Google Scholar]
- 6.Liu Z, Shen Y, Cui N, Yang J. 2011. Clinical observation of immunity for severe acute pancreatitis. Inflammation 34:426–431. doi: 10.1007/s10753-010-9249-5. [DOI] [PubMed] [Google Scholar]
- 7.Porter EM, Bevins CL, Ghosh D, Ganz T. 2002. The multifaceted Paneth cell. Cell Mol Life Sci 59:156–170. doi: 10.1007/s00018-002-8412-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76–83. doi: 10.1038/ni.1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bevins CL, Salzman NH. 2011. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9:356–368. doi: 10.1038/nrmicro2546. [DOI] [PubMed] [Google Scholar]
- 10.Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H. 2011. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415–418. doi: 10.1038/nature09637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, Stone CD, Brunt EM, Xavier RJ, Sleckman BP, Li E, Mizushima N, Stappenbeck TS, Virgin HW, IV.. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259–263. doi: 10.1038/nature07416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Coutinho HB, da Mota HC, Coutinho VB, Robalinho TI, Furtado AF, Walker E, King G, Mahida YR, Sewell HF, Wakelin D. 1998. Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol 51:512–514. doi: 10.1136/jcp.51.7.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Estienne M, Claustre J, Clain-Gardechaux G, Paquet A, Taché Y, Fioramonti J, Plaisancié P. 2010. Maternal deprivation alters epithelial secretory cell lineages in rat duodenum: role of CRF-related peptides. Gut 59:744–751. doi: 10.1136/gut.2009.190728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Guo Y, Huang C, Liu L, Fu X, Lu Y, Zheng J, Mei Q, Huang Z, Fan J, Lu L, Zeng Y. 2019. Paneth cell ablation aggravates pancreatic and intestinal injuries in a rat model of acute necrotizing pancreatitis after normal and high-fat diet. Mediators Inflamm 2019:8474523. doi: 10.1155/2019/8474523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Riba A, Olier M, Lacroix-Lamandé S, Lencina C, Bacquié V, Harkat C, Gillet M, Baron M, Sommer C, Mallet V, Salvador-Cartier C, Laurent F, Théodorou V, Ménard S. 2017. Paneth cell defects induce microbiota dysbiosis in mice and promote visceral hypersensitivity. Gastroenterology 153:1594–1606.e2. doi: 10.1053/j.gastro.2017.08.044. [DOI] [PubMed] [Google Scholar]
- 16.Schoenborn AA, von Furstenberg RJ, Valsaraj S, Hussain FS, Stein M, Shanahan MT, Henning SJ, Gulati AS. 2019. The enteric microbiota regulates jejunal Paneth cell number and function without impacting intestinal stem cells. Gut Microbes 10:45–58. doi: 10.1080/19490976.2018.1474321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lucas López R, Grande Burgos MJ, Gálvez A, Pérez Pulido R. 2017. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS 125:3–10. doi: 10.1111/apm.12609. [DOI] [PubMed] [Google Scholar]
- 18.Shin NR, Whon TW, Bae JW. 2015. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 33:496–503. doi: 10.1016/j.tibtech.2015.06.011. [DOI] [PubMed] [Google Scholar]
- 19.Hayase E, Hashimoto D, Nakamura K, Noizat C, Ogasawara R, Takahashi S, Ohigashi H, Yokoi Y, Sugimoto R, Matsuoka S, Ara T, Yokoyama E, Yamakawa T, Ebata K, Kondo T, Hiramine R, Aizawa T, Ogura Y, Hayashi T, Mori H, Kurokawa K, Tomizuka K, Ayabe T, Teshima T. 2017. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. J Exp Med 214:3507–3518. doi: 10.1084/jem.20170418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Smet A, Menard A. 2020. Review: other Helicobacter species. Helicobacter 25(Suppl 1):e12744. doi: 10.1111/hel.12744. [DOI] [PubMed] [Google Scholar]
- 21.Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. 2021. Blautia—a new functional genus with potential probiotic properties? Gut Microbes 13:1–21. doi: 10.1080/19490976.2021.1875796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Khan J, Pelli H, Lappalainen-Lehto R, Järvinen S, Sand J, Nordback I. 2009. Helicobacter pylori in alcohol induced acute pancreatitis. Scand J Surg 98:221–224. doi: 10.1177/145749690909800405. [DOI] [PubMed] [Google Scholar]
- 23.Fuller MK, Faulk DM, Sundaram N, Shroyer NF, Henning SJ, Helmrath MA. 2012. Intestinal crypts reproducibly expand in culture. J Surg Res 178:48–54. doi: 10.1016/j.jss.2012.03.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Katoh M, Katoh M. 2007. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:4042–4045. doi: 10.1158/1078-0432.CCR-06-2316. [DOI] [PubMed] [Google Scholar]
- 25.Dang CV. 2012. MYC on the path to cancer. Cell 149:22–35. doi: 10.1016/j.cell.2012.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Günther C, Buchen B, He GW, Hornef M, Torow N, Neumann H, Wittkopf N, Martini E, Basic M, Bleich A, Watson AJ, Neurath MF, Becker C. 2015. Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut 64:601–610. doi: 10.1136/gutjnl-2014-307226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Salzman NH, Bevins CL. 2013. Dysbiosis—a consequence of Paneth cell dysfunction. Semin Immunol 25:334–341. doi: 10.1016/j.smim.2013.09.006. [DOI] [PubMed] [Google Scholar]
- 28.Zhong W, Wei X, Hao L, Lin TD, Yue R, Sun X, Guo W, Dong H, Li T, Ahmadi AR, Sun Z, Zhang Q, Zhao J, Zhou Z. 2020. Paneth cell dysfunction mediates alcohol-related steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency. Hepatology 71:1575–1591. doi: 10.1002/hep.30945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, Shimoda S, Iwasaki H, Shimono N, Ayabe T, Akashi K, Teshima T. 2012. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 120:223–231. doi: 10.1182/blood-2011-12-401166. [DOI] [PubMed] [Google Scholar]
- 30.Chen J, Huang C, Wang J, Zhou H, Lu Y, Lou L, Zheng J, Tian L, Wang X, Cao Z, Zeng Y. 2017. Dysbiosis of intestinal microbiota and decrease in Paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats. PLoS One 12:e0176583. doi: 10.1371/journal.pone.0176583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Liu J, Huang L, Luo M, Xia X. 2019. Bacterial translocation in acute pancreatitis. Crit Rev Microbiol 45:539–547. doi: 10.1080/1040841X.2019.1621795. [DOI] [PubMed] [Google Scholar]
- 32.Camargo EA, Santana DG, Silva CI, Teixeira SA, Toyama MH, Cotrim C, Landucci EC, Antunes E, Muscara MN, Costa SK. 2014. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2. Eur J Pain 18:691–700. doi: 10.1002/j.1532-2149.2013.00414.x. [DOI] [PubMed] [Google Scholar]
- 33.Tian R, Tan J-T, Wang R-L, Xie H, Qian Y-B, Yu K-L. 2013. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis. Eur Rev Med Pharmacol Sci 17:349–355. [PubMed] [Google Scholar]
- 34.Zhou C, Fang X, Xu J, Gao J, Zhang L, Zhao J, Meng Y, Zhou W, Han X, Bai Y, Li Z, Zou D. 2020. Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation. Gut Microbes 12:1782156. doi: 10.1080/19490976.2020.1782156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lu R, Zhang YG, Xia Y, Zhang J, Kaser A, Blumberg R, Sun J. 2021. Paneth cell alertness to pathogens maintained by vitamin D receptors. Gastroenterology 160:1269–1283. doi: 10.1053/j.gastro.2020.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zheng J, Lou L, Fan J, Huang C, Mei Q, Wu J, Guo Y, Lu Y, Wang X, Zeng Y. 2019. Commensal Escherichia coli aggravates acute necrotizing pancreatitis through targeting of intestinal epithelial cells. Appl Environ Microbiol 85:e00059-19. doi: 10.1128/AEM.00059-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lei Y, Tang L, Liu S, Hu S, Wu L, Liu Y, Yang M, Huang S, Tang X, Tang T, Zhao X, Vlodavsky I, Zeng S, Tang B, Yang S. 2021. Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration. Microbiome 9:115. doi: 10.1186/s40168-021-01065-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Li X, He C, Li N, Ding L, Chen H, Wan J, Yang X, Xia L, He W, Xiong H, Shu X, Zhu Y, Lu N. 2020. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice. Gut Microbes 11:1774–1789. doi: 10.1080/19490976.2020.1770042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sun D, Bai R, Zhou W, Yao Z, Liu Y, Tang S, Ge X, Luo L, Luo C, Hu GF, Sheng J, Xu Z. 2021. Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachnospiraceae. Gut 70:666–676. doi: 10.1136/gutjnl-2019-320135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho SB, Brenner DA, Hooper LV, Schnabl B. 2016. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 19:227–239. doi: 10.1016/j.chom.2016.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Laible NJ, Germaine GR. 1985. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun 48:720–728. doi: 10.1128/iai.48.3.720-728.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ellison RT, III, Giehl TJ. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88:1080–1091. doi: 10.1172/JCI115407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ragland SA, Criss AK. 2017. From bacterial killing to immune modulation: recent insights into the functions of lysozyme. PLoS Pathog 13:e1006512. doi: 10.1371/journal.ppat.1006512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yu S, Balasubramanian I, Laubitz D, Tong K, Bandyopadhyay S, Lin X, Flores J, Singh R, Liu Y, Macazana C, Zhao Y, Béguet-Crespel F, Patil K, Midura-Kiela MT, Wang D, Yap GS, Ferraris RP, Wei Z, Bonder EM, Häggblom MM, Zhang L, Douard V, Verzi MP, Cadwell K, Kiela PR, Gao N. 2020. Paneth cell-derived lysozyme defines the composition of mucolytic microbiota and the inflammatory tone of the intestine. Immunity 53:398–416.e8. doi: 10.1016/j.immuni.2020.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gao J-J, Zhang Y, Gerhard M, Mejias-Luque R, Zhang L, Vieth M, Ma J-L, Bajbouj M, Suchanek S, Liu W-D, Ulm K, Quante M, Li Z-X, Zhou T, Schmid R, Classen M, Li W-Q, You W-C, Pan K-F. 2018. Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer. Front Cell Infect Microbiol 8:202. doi: 10.3389/fcimb.2018.00202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Corbin AL, Gomez-Vazquez M, Berthold DL, Attar M, Arnold IC, Powrie FM, Sansom SN, Udalova IA. 2020. IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation. Sci Immunol 5:eaax6085. doi: 10.1126/sciimmunol.aax6085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhu L, Zhu C, Cao S, Zhang Q. 2021. Helicobacter hepaticus induce colitis in male IL-10−/− mice dependent by cytolethal distending toxin B and via the activation of Jak/Stat signaling pathway. Front Cell Infect Microbiol 11:616218. doi: 10.3389/fcimb.2021.616218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Alavi S, Mitchell JD, Cho JY, Liu R, Macbeth JC, Hsiao A. 2020. Interpersonal gut microbiome variation drives susceptibility and resistance to cholera infection. Cell 181:1533–1546.e13. doi: 10.1016/j.cell.2020.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Mullish BH, McDonald JAK, Pechlivanis A, Allegretti JR, Kao D, Barker GF, Kapila D, Petrof EO, Joyce SA, Gahan CGM, Glegola-Madejska I, Williams HRT, Holmes E, Clarke TB, Thursz MR, Marchesi JR. 2019. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut 68:1791–1800. doi: 10.1136/gutjnl-2018-317842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wolf AJ, Arruda A, Reyes CN, Kaplan AT, Shimada T, Shimada K, Arditi M, Liu G, Underhill DM. 2011. Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J Immunol 187:6002–6010. doi: 10.4049/jimmunol.1100232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Caruso R, Warner N, Inohara N, Núñez G. 2014. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41:898–908. doi: 10.1016/j.immuni.2014.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Zhang Q, Pan Y, Yan R, Zeng B, Wang H, Zhang X, Li W, Wei H, Liu Z. 2015. Commensal bacteria direct selective cargo sorting to promote symbiosis. Nat Immunol 16:918–926. doi: 10.1038/ni.3233. [DOI] [PubMed] [Google Scholar]
- 53.Wang H, Zhang X, Zuo Z, Zhang Q, Pan Y, Zeng B, Li W, Wei H, Liu Z. 2017. Rip2 is required for Nod2-mediated lysozyme sorting in Paneth cells. J Immunol 198:3729–3736. doi: 10.4049/jimmunol.1601583. [DOI] [PubMed] [Google Scholar]
- 54.Lee M, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y. 2009. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Agric Food Chem 57:2233–2240. doi: 10.1021/jf803133b. [DOI] [PubMed] [Google Scholar]
- 55.Tan SH, Phuah P, Tan LT, Yada S, Goh J, Tomaz LB, Chua M, Wong E, Lee B, Barker N. 2021. A constant pool of Lgr5(+) intestinal stem cells is required for intestinal homeostasis. Cell Rep 34:108633. doi: 10.1016/j.celrep.2020.108633. [DOI] [PubMed] [Google Scholar]
- 56.Wu H, Xie S, Miao J, Li Y, Wang Z, Wang M, Yu Q. 2020. Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa. Gut Microbes 11:997–1014. doi: 10.1080/19490976.2020.1734423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Laukkarinen JM, Van Acker GJ, Weiss ER, Steer ML, Perides G. 2007. A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate. Gut 56:1590–1598. doi: 10.1136/gut.2007.124230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Mei QX, Hu JH, Huang ZH, Fan JJ, Huang CL, Lu YY, Wang XP, Zeng Y. 2021. Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis. Acta Pharmacol Sin 42:942–953. doi: 10.1038/s41401-020-00581-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shimizu T, Shiratori K, Sawada T, Kobayashi M, Hayashi N, Saotome H, Keith JC. 2000. Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 21:134–140. doi: 10.1097/00006676-200008000-00005. [DOI] [PubMed] [Google Scholar]
- 60.Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101:478–483. doi: 10.1001/archsurg.1970.01340280030009. [DOI] [PubMed] [Google Scholar]
- 61.Liu L, Guo Y, Zheng J, Lu Y, Shen Y, Huang C, Zeng Y, Wang X. 2019. Paneth cell ablation increases the small intestinal injury during acute necrotizing pancreatitis in rats. Mol Med Rep 20:473–484. doi: 10.3892/mmr.2019.10274. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw data for 16S rRNA sequencing in this study are available in the SRA database with BioProject accession number PRJNA774193.